These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1661630)

  • 1. Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome.
    Villagrasa M; Boix J; Humbert P; Quer JC
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):67-70. PubMed ID: 1661630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control.
    Defrance P; Casini A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):64-6. PubMed ID: 1756286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Marzio L; Di Felice F
    Hepatogastroenterology; 1992 Oct; 39(5):392-5. PubMed ID: 1459516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide].
    Mollica G; Manno G
    Clin Ter; 1992 Aug; 141(8):129-34. PubMed ID: 1395455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
    Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
    Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of irritable bowel syndrome with dicetelium and spasmomen].
    Nedogoda SV; Parshev VV
    Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
    Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical study on the efficacy of tiropramide hydrochloride in the treatment of irritable colon: comparison with octylonium bromide].
    Tinozzi S; Valesi MG
    Minerva Med; 1984 Jan; 75(1-2):23-31. PubMed ID: 6363985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
    Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategy for the irritable bowel syndrome.
    Castiglione F; Daniele B; Mazzacca G
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):53-5. PubMed ID: 1661628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
    Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
    Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The otilonium bromide-benzodiazepine combination in the therapy of the irritable colon syndrome].
    Capurso L; Del Sette F; Ferrario F; Tarquini M
    Clin Ter; 1992 Aug; 141(8):121-7. PubMed ID: 1395454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a high-fiber diet on symptoms of irritable bowel syndrome: a randomized clinical trial.
    Aller R; de Luis DA; Izaola O; la Calle F; del Olmo L; Fernandez L; Arranz T; González Hernandez JM
    Nutrition; 2004 Sep; 20(9):735-7. PubMed ID: 15325678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome and dietary fiber.
    Achord JL
    J Am Diet Assoc; 1979 Oct; 75(4):452-3. PubMed ID: 113444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of spasmolytic agent otilonium bromide (spasmomen) in digestive endoscopy: a prospective study in 63 patients].
    Gómez NA; León CJ; Gutiérrez J
    Acta Gastroenterol Latinoam; 1997; 27(3):123-5. PubMed ID: 9412140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.